GLIPIZIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for glipizide and what is the scope of freedom to operate?
Glipizide
is the generic ingredient in five branded drugs marketed by Aurobindo Pharma, Endo Operations, Norvium Bioscience, Unique, Watson Labs, Zydus Pharms, Pfizer, Accord Hlthcare, Ani Pharms, Apotex, Aurobindo Pharma Usa, Barr Labs Inc, Chartwell Rx, Oxford Pharms, Rubicon, Sandoz, Sun Pharm Inds Inc, Watson Labs Teva, Dash Pharms, Epic Pharma Llc, Heritage, Teva Pharms, Zydus Pharms Usa Inc, and Bristol Myers Squibb, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.There are eighteen drug master file entries for glipizide. Forty-three suppliers are listed for this compound.
Summary for GLIPIZIDE
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 24 |
NDAs: | 29 |
Drug Master File Entries: | 18 |
Finished Product Suppliers / Packagers: | 43 |
Raw Ingredient (Bulk) Api Vendors: | 123 |
Clinical Trials: | 42 |
Patent Applications: | 6,982 |
Drug Prices: | Drug price trends for GLIPIZIDE |
Drug Sales Revenues: | Drug sales revenues for GLIPIZIDE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for GLIPIZIDE |
What excipients (inactive ingredients) are in GLIPIZIDE? | GLIPIZIDE excipients list |
DailyMed Link: | GLIPIZIDE at DailyMed |
Recent Clinical Trials for GLIPIZIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Memorial Sloan Kettering Cancer Center | Phase 2 |
University of Michigan | Phase 1 |
Food and Drug Administration (FDA) | Phase 1 |
Pharmacology for GLIPIZIDE
Drug Class | Sulfonylurea |
Medical Subject Heading (MeSH) Categories for GLIPIZIDE
Anatomical Therapeutic Chemical (ATC) Classes for GLIPIZIDE
US Patents and Regulatory Information for GLIPIZIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Unique | GLIPIZIDE | glipizide | TABLET, EXTENDED RELEASE;ORAL | 204720-002 | Dec 29, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sandoz | GLIPIZIDE | glipizide | TABLET;ORAL | 074305-002 | Apr 7, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sandoz | GLIPIZIDE | glipizide | TABLET;ORAL | 074305-001 | Apr 7, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Dash Pharms | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | glipizide; metformin hydrochloride | TABLET;ORAL | 078083-002 | Apr 12, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Unique | GLIPIZIDE | glipizide | TABLET, EXTENDED RELEASE;ORAL | 204720-001 | Dec 29, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Watson Labs Teva | GLIPIZIDE | glipizide | TABLET;ORAL | 074223-001 | Feb 27, 1995 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva Pharms | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | glipizide; metformin hydrochloride | TABLET;ORAL | 077270-002 | Oct 28, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for GLIPIZIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-002 | Apr 26, 1994 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-001 | Apr 26, 1994 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-001 | Apr 26, 1994 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-003 | Aug 10, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | GLUCOTROL | glipizide | TABLET;ORAL | 017783-002 | May 8, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-002 | Apr 26, 1994 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-003 | Aug 10, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.